Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
248.93
-0.08 (-0.03%)
Nov 3, 2026, 4:00 PM EST - Market closed
Biogen Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Maintains $250 | Hold | Maintains | $250 | +0.43% | Nov 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $251 → $270 | Buy | Reiterates | $251 → $270 | +8.46% | Nov 2, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $280 → $300 | Buy | Maintains | $280 → $300 | +20.52% | Nov 2, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $235 → $260 | Buy | Maintains | $235 → $260 | +4.45% | Oct 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $242 → $286 | Buy | Maintains | $242 → $286 | +14.89% | Oct 30, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Maintains $255 → $275 | Buy | Maintains | $255 → $275 | +10.47% | Oct 29, 2026 |
| Argus Research | Argus Research | Buy Upgrades $280 | Buy | Upgrades | $280 | +12.48% | Oct 29, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $238 | Hold | Maintains | $238 | -4.39% | Oct 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.